Correlation Between Sensient Technologies and EnVVeno Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sensient Technologies and EnVVeno Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sensient Technologies and EnVVeno Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sensient Technologies and enVVeno Medical Corp, you can compare the effects of market volatilities on Sensient Technologies and EnVVeno Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sensient Technologies with a short position of EnVVeno Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sensient Technologies and EnVVeno Medical.

Diversification Opportunities for Sensient Technologies and EnVVeno Medical

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Sensient and EnVVeno is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Sensient Technologies and enVVeno Medical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enVVeno Medical Corp and Sensient Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sensient Technologies are associated (or correlated) with EnVVeno Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enVVeno Medical Corp has no effect on the direction of Sensient Technologies i.e., Sensient Technologies and EnVVeno Medical go up and down completely randomly.

Pair Corralation between Sensient Technologies and EnVVeno Medical

Considering the 90-day investment horizon Sensient Technologies is expected to generate 0.4 times more return on investment than EnVVeno Medical. However, Sensient Technologies is 2.47 times less risky than EnVVeno Medical. It trades about 0.08 of its potential returns per unit of risk. enVVeno Medical Corp is currently generating about -0.02 per unit of risk. If you would invest  5,459  in Sensient Technologies on September 4, 2024 and sell it today you would earn a total of  2,386  from holding Sensient Technologies or generate 43.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sensient Technologies  vs.  enVVeno Medical Corp

 Performance 
       Timeline  
Sensient Technologies 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sensient Technologies are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Sensient Technologies is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
enVVeno Medical Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days enVVeno Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Sensient Technologies and EnVVeno Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sensient Technologies and EnVVeno Medical

The main advantage of trading using opposite Sensient Technologies and EnVVeno Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sensient Technologies position performs unexpectedly, EnVVeno Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will offset losses from the drop in EnVVeno Medical's long position.
The idea behind Sensient Technologies and enVVeno Medical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance